BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fisher Asset Management, LLC 3,185,199$22,551,2080.01%
Squarepoint Ops LLC 746,102$5,282,4020.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 343,848$2,434,4440.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 384,000$2,718,7200.01%
Gotham Asset Management, LLC 69,033$488,7540.01%
China Universal Asset Management Co., Ltd. 4,865$340.01%
J.W. COLE ADVISORS, INC. 19,900$140,8920.01%
Skandinaviska Enskilda Banken AB (publ) 190,541$1,3490.01%
Waverly Advisors, LLC 24,879$176,1430.01%
ALPS ADVISORS INC 139,850$990,1380.01%
Rehmann Capital Advisory Group 12,141$85,9580.01%
VOYA INVESTMENT MANAGEMENT LLC 927,652$6,567,7760.01%
TUDOR INVESTMENT CORP ET AL 94,435$668,6000.01%
Caption Management, LLC 62,500$442,5000.01%
OSAIC HOLDINGS, INC. 649,318$4,597,1700.01%
GUGGENHEIM CAPITAL LLC 122,322$866,0400.01%
Nuveen Asset Management, LLC 2,573,340$18,219,2480.01%
Diversified Trust Co 20,978$148,5240.01%
Graham Capital Management, L.P. 37,526$265,6840.01%
BALYASNY ASSET MANAGEMENT L.P. 408,297$2,890,7430.01%
External links

This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.